Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Baton Rouge Vascular Access

Request full access

Us-based company operating in the healthcare sector

Baton Rouge, United StatesFounded 2011Biotech & Life Sciences

About Baton Rouge Vascular Access

Baton Rouge Vascular Access operates as a specialized outpatient center providing minimally invasive vascular care, primarily serving the community of Baton Rouge, Louisiana since 2002. The facility is part of Azura Vascular Care, a national network of ambulatory surgery centers that was rebranded from Fresenius Vascular Care in June 2017. This network is a division of Fresenius Medical Care North America, a major provider of renal and chronic condition care. The strategic rebranding to Azura Vascular Care was initiated to unify over 65 centers under a single brand, reflecting a broader scope of services beyond its original renal focus and enhancing national brand awareness.

The business model centers on providing cost-effective vascular treatments in a comfortable outpatient setting, serving as an alternative to hospital-based procedures. Azura Vascular Care operates through various business models, including joint ventures with physicians, managing ambulatory surgery centers, and acting as extensions of physician practices. This structure is designed to offer entrepreneurial physicians a collaborative platform while maintaining clinical autonomy. The parent company, Fresenius Medical Care North America, has a history of strategic acquisitions to expand its vascular care services, including the acquisition of National Vascular Care in 2010 and American Access Care Holdings in 2011.

Baton Rouge Vascular Access specializes in dialysis access management for patients with end-stage renal disease (ESRD) and the treatment of peripheral artery disease (PAD). The center provides procedures such as fistulagrams, thrombectomies, and catheter insertions and removals. The medical team includes interventional nephrologists and vascular surgeons, such as Dr. Christopher Peter Luscy and Dr. Wajeeh Irfan, who are focused on using up-to-date techniques to improve patient quality of life. The broader Azura network treats a wide array of vascular conditions, including uterine fibroids, varicose veins, and varicoceles, positioning itself to serve the nearly one in five Americans affected by some form of vascular disease.

Source: Dealroom company data

At a glance

Status
Operational
Employees
206
Open positions
None listed
Dealroom signal
26.7/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotechnology, Surgery, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Nov 2011 $11M $44M Undisclosed —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Baton Rouge Vascular Access website traffic

Latest recorded traffic for Baton Rouge Vascular Access is 24K monthly website visits, up 33.3% over the last three months. Baton Rouge Vascular Access's team declined 14.5% over the past year.

Latest monthly visits24K 3-month web change+33.3% 1-year team growth-14.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Baton Rouge Vascular Access in the Baton Rouge ecosystem

Live from Dealroom

The Baton Rouge Vascular Access office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Baton Rouge Vascular Access on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Baton Rouge Vascular Access’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.